NeuroOne Medical Technologies
NMTC
15 hedge funds and large institutions have $1.55M invested in NeuroOne Medical Technologies in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
79% more capital invested
Capital invested by funds: $867K → $1.55M (+$682K)
0.24% more ownership
Funds ownership: 0.74% → 0.98% (+0.24%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less funds holding
Funds holding: 20 → 15 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$548K |
| 2 |
SG Americas Securities
New York
|
+$88.4K |
| 3 |
PGAM
Princeton Global Asset Management
Princeton,
New Jersey
|
+$26K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$3.08K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$103K |
| 2 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$46.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$43.3K |
| 4 |
Jane Street
New York
|
-$25.4K |
| 5 |
VF
Virtu Financial
New York
|
-$18K |
NMTC Hedge Fund Activity: Q1 2023 in Review
15 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q1 2023, worth a combined $1.55M — up 79% from $867K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NMTC and 3 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $548K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $103K sold.
- 15 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q1 2023, down from 20 in Q4 2022.
- Funds reported $1.55M of NeuroOne Medical Technologies stock for Q1 2023, up 79% quarter-over-quarter.
- 3 funds opened new NeuroOne Medical Technologies positions in Q1 2023 and 8 closed out, a net change of -5 holders.
- The largest NeuroOne Medical Technologies buyer in Q1 2023 was Vanguard Group, an estimated $548K added.
- The largest NeuroOne Medical Technologies seller in Q1 2023 was Susquehanna International Group, an estimated $103K sold.
Based on aggregated 13F filings for Q1 2023.